ADMA elevation does not exacerbate development of diabetic nephropathy in mice with streptozotocin-induced diabetes mellitus
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:40 |
|---|---|
| Enthalten in: |
Atherosclerosis. Supplements - 40(2019), Seite 100-105 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Rodionov, Roman N., 1978- [VerfasserIn] |
|---|
| Links: |
dx.doi.org [kostenfrei] |
|---|
| doi: |
10.1016/j.atherosclerosissup.2019.08.040 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
1686086423 |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | 1686086423 | ||
| 003 | DE-627 | ||
| 005 | 20211010222658.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 191219s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.atherosclerosissup.2019.08.040 |2 doi | |
| 035 | |a (DE-627)1686086423 | ||
| 035 | |a (DE-599)KXP1686086423 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 100 | 1 | |a Rodionov, Roman N. |d 1978- |e verfasserin |0 (DE-588)1152105205 |0 (DE-627)1013621212 |0 (DE-576)499556089 |4 aut | |
| 245 | 1 | 0 | |a ADMA elevation does not exacerbate development of diabetic nephropathy in mice with streptozotocin-induced diabetes mellitus |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 700 | 1 | |a Jarzebska, Natalia |e verfasserin |4 aut | |
| 700 | 1 | |a Schneider, Alfred |e verfasserin |4 aut | |
| 700 | 1 | |a Rexin, Annett |e verfasserin |4 aut | |
| 700 | 1 | |a Sradnick, Jan Eberhard |d 1981- |e verfasserin |0 (DE-588)143368958 |0 (DE-627)704467305 |0 (DE-576)336688997 |4 aut | |
| 700 | 1 | |a Brilloff, Silke |e verfasserin |4 aut | |
| 700 | 1 | |a Martens-Lobenhoffer, Jens |e verfasserin |4 aut | |
| 700 | 1 | |a Bode-Böger, Stefanie M. |e verfasserin |4 aut | |
| 700 | 1 | |a Todorov, Vladimir |e verfasserin |4 aut | |
| 700 | 1 | |a Hugo, Christian |d 1962- |e verfasserin |0 (DE-588)1098547799 |0 (DE-627)857727516 |0 (DE-576)469155841 |4 aut | |
| 700 | 1 | |a Weiss, Norbert |e verfasserin |4 aut | |
| 700 | 1 | |a Hohenstein, Bernd |d 1972- |e verfasserin |0 (DE-588)122158636 |0 (DE-627)705793540 |0 (DE-576)293123349 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Atherosclerosis. Supplements |d Amsterdam [u.a.] : Elsevier Science, 2000 |g 40(2019), Seite 100-105 |h Online-Ressource |w (DE-627)360058922 |w (DE-600)2098677-4 |w (DE-576)103116958 |x 1878-5050 |7 nnns |
| 773 | 1 | 8 | |g volume:40 |g year:2019 |g pages:100-105 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.atherosclerosissup.2019.08.040 |x Resolving-System |z kostenfrei |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ILN_178 | ||
| 912 | |a SYSFLAG_1 | ||
| 912 | |a GBV_KXP | ||
| 912 | |a GBV_ILN_23 | ||
| 912 | |a GBV_ILN_31 | ||
| 912 | |a GBV_ILN_2011 | ||
| 912 | |a GBV_ILN_2025 | ||
| 912 | |a GBV_ILN_2111 | ||
| 912 | |a GBV_ILN_4035 | ||
| 912 | |a GBV_ILN_4037 | ||
| 912 | |a GBV_ILN_4126 | ||
| 912 | |a GBV_ILN_4249 | ||
| 912 | |a GBV_ILN_4305 | ||
| 912 | |a GBV_ILN_4306 | ||
| 912 | |a GBV_ILN_4313 | ||
| 912 | |a GBV_ILN_2403 | ||
| 912 | |a GBV_ILN_2403 | ||
| 912 | |a ISIL_DE-LFER | ||
| 936 | u | w | |d 40 |j 2019 |h 100-105 |
| 951 | |a AR | ||
| 952 | |d 40 |j 2019 |h 100-105 | ||
| 980 | |2 178 |1 01 |x 3178 |b 3567203770 |y x |z 19-12-19 | ||
| 980 | |2 2403 |1 01 |x DE-LFER |b 359669485X |c 00 |f --%%-- |d --%%-- |e n |j --%%-- |y l01 |z 19-02-20 | ||
| 981 | |2 2403 |1 01 |x DE-LFER |r http://dx.doi.org/10.1016/j.atherosclerosissup.2019.08.040 | ||
| 982 | |2 178 |1 00 |x 3178 |8 00 |0 (DE-627)504261622 |a Institut für Klinische Pharmakologie <Magdeburg> | ||
| 982 | |2 178 |1 00 |x 3178 |8 01 |a Martens-Lobenhoffer, Jens / IKP | ||
| 982 | |2 178 |1 00 |x 3178 |8 02 |a Bode-Böger, Stefanie M. / IKP | ||
| 982 | |2 178 |1 00 |x 3178 |8 03 |0 (DE-627)719906830 |a begutachteter Zeitschriftenartikel (peer reviewed) | ||
| 982 | |2 178 |1 00 |x 3178 |8 04 |a Open Access | ||
| 983 | |2 178 |1 00 |x 3178 |8 00 |a Impact factor: 2.350 | ||
| 983 | |2 178 |1 01 |x 3178 |8 99 |a j2019 | ||